| human | Q5 |
| P227 | GND ID | 1222202069 |
| P496 | ORCID iD | 0000-0002-4570-8462 |
| P1053 | ResearcherID | M-4428-2016 |
| P1153 | Scopus author ID | 7102021660 |
| P214 | VIAF ID | 36409798 |
| P27 | country of citizenship | Italy | Q38 |
| P69 | educated at | University of Milan-Bicocca | Q1073674 |
| P108 | employer | University of Milan-Bicocca | Q1073674 |
| P734 | family name | Nicoletti | Q21494540 |
| Nicoletti | Q21494540 | ||
| Nicoletti | Q21494540 | ||
| P735 | given name | Ferdinando | Q17523781 |
| Ferdinando | Q17523781 | ||
| P1412 | languages spoken, written or signed | Italian | Q652 |
| P106 | occupation | researcher | Q1650915 |
| P21 | sex or gender | male | Q6581097 |
| Q43269062 | 16alpha-Bromoepiandrosterone (HE2000) limits non-productive inflammation and stimulates immunity in lungs |
| Q34424228 | 5-androstenediol ameliorates pleurisy, septic shock, and experimental autoimmune encephalomyelitis in mice |
| Q40200249 | A potent immunomodulatory compound, (S,R)-3-Phenyl-4,5-dihydro-5-isoxazole acetic acid, prevents spontaneous and accelerated forms of autoimmune diabetes in NOD mice and inhibits the immunoinflammatory diabetes induced by multiple low doses of strep |
| Q45362554 | Acceleration of SLE-like syndrome development in NZBxNZW F1 mice by beta-glucan. |
| Q38665896 | Acquired Immune Resistance Follows Complete Tumor Regression without Loss of Target Antigens or IFNγ Signaling. |
| Q27686983 | Advances in targeting signal transduction pathways |
| Q49274434 | Ageing: from inflammation to cancer |
| Q81768393 | Akt as a therapeutic target in cancer |
| Q78232870 | Amelioration of experimental allergic neuritis by sodium fusidate (fusidin): suppression of IFN-gamma and TNF-alpha and enhancement of IL-10 |
| Q44625703 | Anti-inflammatory and immune regulatory properties of 5-androsten-3beta, 17beta-diol (HE2100), and synthetic analogue HE3204: implications for treatment of autoimmune diseases. |
| Q74090254 | Antibiotic susceptibility of group A streptococci in 2 Italian cities: Milano and Catania |
| Q41126709 | Antibodies to endothelial cells in primary vasculitides mediate in vitro endothelial cytotoxicity in the presence of normal peripheral blood mononuclear cells. |
| Q24628715 | Anticancer effects of the nitric oxide-modified saquinavir derivative saquinavir-NO against multidrug-resistant cancer cells |
| Q40001479 | Anticancer properties of the novel nitric oxide-donating compound (S,R)-3-phenyl-4,5-dihydro-5-isoxazole acetic acid-nitric oxide in vitro and in vivo. |
| Q47925346 | Apotransferrin inhibits interleukin-2 expression and protects mice from experimental autoimmune encephalomyelitis. |
| Q58503283 | Applying the FRAD Conceptual Model to an Authority File for Manuscripts: Analysis of a Local Implementation |
| Q43447772 | Association of chitotriosidase genotype with the development of non-alcoholic fatty liver disease. |
| Q44525307 | Association of t(14;18) translocation with HCV infection in gastrointestinal MALT lymphomas. |
| Q59090838 | B9. Tumoricidal activity of GIT-27NO depends on RNS and ROS generation |
| Q42417533 | BRAF inhibition improves tumor recognition by the immune system: Potential implications for combinatorial therapies against melanoma involving adoptive T-cell transfer |
| Q58880736 | Beneficial effects of r-h-CLU on disease severity in different animal models of peripheral neuropathies |
| Q72296820 | Biphasic effect of interferon-gamma in murine collagen-induced arthritis |
| Q47712305 | Blood levels of transforming growth factor-beta 1 (TGF-beta1) are elevated in both relapsing remitting and chronic progressive multiple sclerosis (MS) patients and are further augmented by treatment with interferon-beta 1b (IFN-beta1b). |
| Q59090822 | C20. Novel NO-donation compound GIT-27NO possesses strong tumoricidal capacity in vitro and in vivo |
| Q62604182 | C21. GIT-27 NO may be a potential therapeutic agent for melanoma treatment by inhibition of the transcription repressor YIN-YANG |
| Q40701666 | CD4+ T-cell gene expression of healthy donors, HIV-1 and elite controllers: Immunological chaos. |
| Q41472027 | Carbon monoxide-releasing molecule-A1 (CORM-A1) improves clinical signs of experimental autoimmune uveoretinitis (EAU) in rats |
| Q91657431 | Characterization of the Pathophysiological Role of CD47 in Uveal Melanoma |
| Q53278968 | Chitotriosidase and inflammatory mediator levels in Alzheimer's disease and cerebrovascular dementia. |
| Q35768951 | Chitotriosidase gene expression in Kupffer cells from patients with non-alcoholic fatty liver disease |
| Q58856617 | Chronic Administration of UK-114, a Multifunctional Emerging Protein, Modulates the Th1/Th2 Cytokine Pattern and Experimental Autoimmune Diseases |
| Q71311050 | Circulating serum levels of IL-1ra in patients with relapsing remitting multiple sclerosis are normal during remission phases but significantly increased either during exacerbations or in response to IFN-beta treatment |
| Q35464054 | Combination of cyclophosphamide and interferon-beta halts progression in patients with rapidly transitional multiple sclerosis |
| Q39319803 | Comparative study of rapamycin and temsirolimus demonstrates superimposable anti-tumour potency on prostate cancer cells. |
| Q100746594 | Comprehensive Analysis of RNA-Seq Gene Expression Profiling of Brain Transcriptomes Reveals Novel Genes, Regulators, and Pathways in Autism Spectrum Disorder |
| Q28551002 | Computational Modeling of PI3K/AKT and MAPK Signaling Pathways in Melanoma Cancer |
| Q52538075 | Concanavalin A-induced hepatitis in mice is prevented by interleukin (IL)-10 and exacerbated by endogenous IL-10 deficiency. |
| Q89216257 | Contribution of the macrophage migration inhibitory factor superfamily of cytokines in the pathogenesis of preclinical and human multiple sclerosis: In silico and in vivo evidences |
| Q59090670 | Control of the of the final stage of immune-mediated diabetes by ISO-1, an antagonist of macrophage migration inhibitory factor |
| Q41199140 | Correlation between islet cell antibodies and anti-cytomegalovirus IgM and IgG antibodies in healthy first-degree relatives of type 1 (insulin-dependent) diabetic patients. |
| Q46896659 | Corrigendum to "Expression of DNA methylation genes in secondary progressive multiple sclerosis" [J. Neuroimmunol. 290 (2016 Jan. 15) 66-9]. |
| Q38762743 | Critical Roles of EGFR Family Members in Breast Cancer and Breast Cancer Stem Cells: Targets for Therapy |
| Q46404265 | Critical role of macrophage migration inhibitory factor activity in experimental autoimmune diabetes |
| Q35257531 | Crude extract of hydatid laminated layer from Echinococcus granulosus cyst attenuates mucosal intestinal damage and inflammatory responses in Dextran Sulfate Sodium induced colitis in mice |
| Q46974506 | Curative effects of recombinant human Interleukin-6 in DA rats with protracted relapsing experimental allergic encephalomyelitis |
| Q44707630 | Curative effects of sodium fusidate on the development of dinitrobenzenesulfonic acid-induced colitis in rats |
| Q40545742 | Cyclin D1 and Ewing's sarcoma/PNET: A microarray analysis |
| Q53297192 | Cyclin D1 in pediatric neuroblastic tumors: A microarray analysis. |
| Q34179539 | Cytotoxic and immune-sensitizing properties of nitric oxide-modified Saquinavir in iNOS-positive human melanoma cells. |
| Q89344868 | Decitabine induces regulatory T cells, inhibits the production of IFN-gamma and IL-17 and exerts preventive and therapeutic efficacy in rodent experimental autoimmune neuritis |
| Q74485921 | Deoxyspergualin neither counteracts lipopolysaccharide (LPS) or Staphylococcus aureus enterotoxin-B (SEB) induced lethality in mice nor does it modulate the release of tumor necrosis factor-alpha |
| Q34103963 | Deregulation of the EGFR/PI3K/PTEN/Akt/mTORC1 pathway in breast cancer: possibilities for therapeutic intervention |
| Q50192335 | Diagnostic utility of cyclin D1 in the diagnosis of small round blue cell tumors in children and adolescents. |
| Q37192602 | Dominant roles of the Raf/MEK/ERK pathway in cell cycle progression, prevention of apoptosis and sensitivity to chemotherapeutic drugs |
| Q73224783 | Early prophylaxis with recombinant human interleukin-11 prevents spontaneous diabetes in NOD mice |
| Q36556350 | Ectopic NGAL expression can alter sensitivity of breast cancer cells to EGFR, Bcl-2, CaM-K inhibitors and the plant natural product berberine |
| Q31798443 | Effect of octreotide on insulin requirement, hepatic glucose production, growth hormone, glucagon and c-peptide levels in type 2 diabetic patients with chronic renal failure or normal renal function. |
| Q99605676 | Effects of Combined Admistration of Imatinib and Sorafenib in a Murine Model of Liver Fibrosis |
| Q41026728 | Effects of NO-Hybridization on the Immunomodulatory Properties of the HIV Protease Inhibitors Lopinavir and Ritonavir |
| Q38408983 | Effects of mutations in Wnt/β-catenin, hedgehog, Notch and PI3K pathways on GSK-3 activity-Diverse effects on cell growth, metabolism and cancer |
| Q74245736 | Effects of octreotide on glycaemic control, glucose disposal, hepatic glucose production and counterregulatory hormones secretion in type 1 and type 2 insulin treated diabetic patients |
| Q39370677 | Effects of resveratrol, curcumin, berberine and other nutraceuticals on aging, cancer development, cancer stem cells and microRNAs |
| Q36977464 | Effects of the immunomodulator, VGX-1027, in endotoxin-induced uveitis in Lewis rats. |
| Q79796069 | Effects of tumour necrosis factor-alpha on human sperm motility and apoptosis |
| Q42995372 | Elevated Serum Levels of Osteopontin in HCV-Associated Lymphoproliferative Disorders. |
| Q71664308 | Elevated serum levels of interleukin-12 in chronic progressive multiple sclerosis |
| Q37691441 | Emerging MEK inhibitors. |
| Q102073248 | Emerging Neurological and Psychobiological Aspects of COVID-19 Infection |
| Q37588717 | Emerging Raf inhibitors. |
| Q90189697 | Emerging Role of the Macrophage Migration Inhibitory Factor Family of Cytokines in Neuroblastoma. Pathogenic Effectors and Novel Therapeutic Targets? |
| Q38622303 | Emerging therapeutic targets for the treatment of hepatic fibrosis |
| Q78127448 | Endogenous interleukin-12 only plays a key pathogenetic role in non-obese diabetic mouse diabetes during the very early stages of the disease |
| Q34021310 | Endothelial activation by aPL: a potential pathogenetic mechanism for the clinical manifestations of the syndrome |
| Q45059124 | Enhanced percentage of CD5+ B lymphocytes in newly diagnosed IDDM patients |
| Q41171601 | Enhanced percentage of Leu M3+DR+ and Leu M3+CD25+ cells in newly diagnosed IDDM patients |
| Q37192616 | Enhancing therapeutic efficacy by targeting non-oncogene addicted cells with combinations of signal transduction inhibitors and chemotherapy |
| Q73774662 | Essential pathogenetic role for interferon (IFN-)gamma in concanavalin A-induced T cell-dependent hepatitis: exacerbation by exogenous IFN-gamma and prevention by IFN-gamma receptor-immunoglobulin fusion protein |
| Q74404645 | Essential pathogenic role for endogenous interferon-gamma (IFN-gamma) during disease onset phase of murine experimental autoimmune orchitis. I. In vivo studies |
| Q44528111 | Essential pathogenic role of endogenous IL-18 in murine diabetes induced by multiple low doses of streptozotocin. Prevention of hyperglycemia and insulitis by a recombinant IL-18-binding protein: Fc construct |
| Q41672151 | Evaluation of hyaluronic acid-P40 conjugated cream in a mouse model of dermatitis induced by oxazolone. |
| Q59487961 | Exacerbation of protracted-relapsing experimental allergic encephalomyelitis in DA rats by gluten-free diet |
| Q35679369 | Exploiting p53 status to enhance effectiveness of chemotherapy by lowering associated toxicity |
| Q90397354 | Exploratory Analysis of iPSCS-Derived Neuronal Cells as Predictors of Diagnosis and Treatment of Alzheimer Disease |
| Q81571691 | Extracellular lysosome-associated membrane protein-1 (LAMP-1) mediates autoimmune disease progression in the NOD model of type 1 diabetes |
| Q37739271 | Extrahepatic disorders of HCV infection: a distinct entity of B-cell neoplasia? |
| Q67707500 | FK-506 prevents diabetes in diabetes-prone BB/Wor rats |
| Q78094008 | Failure of exogenously administered interferon-gamma or blockage of endogenous interleukin-4 with specific inhibitors to augment the incidence of autoimmune diabetes in male NOD mice |
| Q37364186 | Fluoxetine Prevents Aβ1-42-Induced Toxicity via a Paracrine Signaling Mediated by Transforming-Growth-Factor-β1. |
| Q92366107 | Food toxicology: quantitative analysis of the research field literature |
| Q41340891 | Fusidic acid and insulin-dependent diabetes mellitus |
| Q27013811 | GSK-3 as potential target for therapeutic intervention in cancer |
| Q90283575 | Gasotransmitters and the immune system: Mode of action and novel therapeutic targets |
| Q73501436 | Genetic differences in immune reactivity to mercuric chloride (HgCl2): immunosuppression of H-2d mice is mediated by interferon-gamma (IFN-gamma) |
| Q34321838 | HE3286, an oral synthetic steroid, treats lung inflammation in mice without immune suppression. |
| Q60981613 | HE3286, an orally bioavailable synthetic analogue of an active DHEA metabolite suppresses spontaneous autoimmune diabetes in the non-obese diabetic (NOD) mouse |
| Q43275853 | HE3286: a novel synthetic steroid as an oral treatment for autoimmune disease |
| Q39015233 | HIV-protease inhibitors for the treatment of cancer: Repositioning HIV protease inhibitors while developing more potent NO-hybridized derivatives? |
| Q43411949 | Heme oxygenase-1 expression in peripheral blood mononuclear cells correlates with disease activity in multiple sclerosis |
| Q47973524 | Human anticardiolipin monoclonal autoantibodies cause placental necrosis and fetal loss in BALB/c mice |
| Q60981582 | Hypomethylating Agent 5-Aza-2′-deoxycytidine (DAC) Ameliorates Multiple Sclerosis in Mouse Models |
| Q48550682 | IL-18 binding protein fusion construct delays the development of diabetes in adoptive transfer and cyclophosphamide-induced diabetes in NOD mouse |
| Q46663769 | ISO-1 binding to the tautomerase active site of MIF inhibits its pro-inflammatory activity and increases survival in severe sepsis |
| Q38901800 | Identification of novel chemotherapeutic strategies for metastatic uveal melanoma. |
| Q38461199 | Identification of novel targets for the diagnosis and treatment of liver fibrosis. |
| Q102376668 | Immune-Modulating Drug MP1032 with SARS-CoV-2 Antiviral Activity In Vitro: A potential Multi-Target Approach for Prevention and Early Intervention Treatment of COVID-19 |
| Q77492453 | Immunomodulation of murine experimental SLE-like disease by interferon-gamma |
| Q44311271 | Immunosuppressive activity of 15-deoxyspergualin on normal and autoimmune peripheral blood mononuclear cells |
| Q92811313 | Impaired Expression of Tetraspanin 32 (TSPAN32) in Memory T Cells of Patients with Multiple Sclerosis |
| Q39602151 | In vitro and in vivo anticancer action of Saquinavir-NO, a novel nitric oxide-derivative of the protease inhibitor saquinavir, on hormone resistant prostate cancer cells. |
| Q46675288 | In vitro inhibition of enterobacteria-reactive CD4+CD25- T cells and suppression of immunoinflammatory colitis in mice by the novel immunomodulatory agent VGX-1027. |
| Q71352635 | In vitro type-1 and type-2 cytokine production in systemic lupus erythematosus: lack of relationship with clinical disease activity |
| Q59090802 | In vitro, ex vivo and in vivo immunopharmacological activities of the isoxazoline compound VGX-1027: Modulation of cytokine synthesis and prevention of both organ-specific and systemic autoimmune diseases in murine models |
| Q46838308 | In vivo treatment with a monoclonal antibody to interferon-gamma neither affects the survival nor the incidence of lupus-nephritis in the MRL/lpr-lpr mouse |
| Q67471480 | Increased rate of survival in Streptococcus pneumoniae-infected rats treated with the new immunomodulator Pidotimod |
| Q74250754 | Increased serum levels of interleukin-18 in patients with multiple sclerosis |
| Q39827640 | Induction of OAS gene family in HIV monocyte infected patients with high and low viral load. |
| Q39746181 | Induction of caspase-independent apoptotic-like cell death of mouse mammary tumor TA3Ha cells in vitro and reduction of their lethality in vivo by the novel chemotherapeutic agent GIT-27NO. |
| Q39303806 | Inhibition of human immunodeficiency virus (HIV-1) infection in human peripheral blood leucocytes-SCID reconstituted mice by rapamycin |
| Q42441577 | Insulin lispro is as effective as regular insulin in optimising metabolic control and preserving beta-cell function at onset of type 1 diabetes mellitus |
| Q45076315 | Interleukin (IL)-1beta toxicity to islet beta cells: Efaroxan exerts a complete protection. |
| Q78060350 | Interleukin-13 prevents autoimmune diabetes in NOD mice |
| Q35556981 | Involvement of Akt and mTOR in chemotherapeutic- and hormonal-based drug resistance and response to radiation in breast cancer cells |
| Q35640228 | Involvement of Akt-1 and mTOR in sensitivity of breast cancer to targeted therapy |
| Q46441674 | Involvement of p53 and Raf/MEK/ERK pathways in hematopoietic drug resistance |
| Q47790004 | Involvement of the Nrf2/HO-1/CO axis and therapeutic intervention with the CO-releasing molecule CORM-A1, in a murine model of autoimmune hepatitis. |
| Q43709051 | MFP14, a multifunctional emerging protein with immunomodulatory properties, prevents spontaneous and recurrent autoimmune diabetes in NOD mice |
| Q37250048 | MIF in autoimmunity and novel therapeutic approaches. |
| Q104748716 | Macrophage Migration Inhibitory Factor (MIF) and Its Homologue d-Dopachrome Tautomerase (DDT) Inversely Correlate with Inflammation in Discoid Lupus Erythematosus |
| Q28260247 | Macrophage migration inhibitory factor (MIF) is necessary for progression of autoimmune diabetes mellitus |
| Q60981678 | Macrophage migration inhibitory factor (MIF) seems crucially involved in Guillain–Barré syndrome and experimental allergic neuritis |
| Q77540681 | Macrophage-derived cytokines in the follicular fluids of women with infertility due to immunological causes. Elevated levels of interleukin 6 and low levels of granulocyte-macrophage colony-stimulating factor |
| Q91668975 | Meta-Analysis of Transcriptomic Data of Dorsolateral Prefrontal Cortex and of Peripheral Blood Mononuclear Cells Identifies Altered Pathways in Schizophrenia |
| Q93126084 | Modulation of Tetraspanin 32 (TSPAN32) Expression in T Cell-Mediated Immune Responses and in Multiple Sclerosis |
| Q64925879 | Modulation of heat shock proteins during macrophage differentiation. |
| Q37437295 | Molecular mechanisms involved in NAFLD progression |
| Q37460101 | Multifaceted roles of GSK-3 and Wnt/β-catenin in hematopoiesis and leukemogenesis: opportunities for therapeutic intervention. |
| Q72996711 | Murine concanavalin A-induced hepatitis is prevented by interleukin 12 (IL-12) antibody and exacerbated by exogenous IL-12 through an interferon-gamma-dependent mechanism |
| Q88361356 | Naturally occurring compounds in differentiation based therapy of cancer |
| Q92630042 | Neuroprotective Mechanisms of Three Natural Antioxidants on a Rat Model of Parkinson's Disease: A Comparative Study |
| Q37760237 | New perspectives in HCV therapy: entry inhibitors. |
| Q60981597 | No-Modified Saquinavir is Equally Efficient Against Doxorubicin Sensitive and Resistant Non-Small Cell Lung Carcinoma Cells / MODIFIKOVANA KOVANA FORMA SAKVINAVIRA EFIKASNO SU PRIMI RA RAST ĆELIJA NESITNOĆELIJSKOG KARCINOMA PLUĆA RAZLIČITE OSETUI |
| Q44157180 | Nondepleting anti-CD4 and soluble interleukin-1 receptor prevent autoimmune destruction of syngeneic islet grafts in diabetic NOD mice |
| Q60981616 | Novel components of the human metabolome: The identification, characterization and anti-inflammatory activity of two 5-androstene tetrols |
| Q39984965 | Novel nitric oxide-donating compound (S,R)-3-phenyl-4,5-dihydro-5-isoxazole acetic acid-nitric oxide (GIT-27NO) induces p53 mediated apoptosis in human A375 melanoma cells. |
| Q36755475 | Oral Delivery of Particulate Transforming Growth Factor Beta 1 and All-Trans Retinoic Acid Reduces Gut Inflammation in Murine Models of Inflammatory Bowel Disease |
| Q43144487 | Oral treatment with HE3286 ameliorates disease in rodent models of rheumatoid arthritis |
| Q90850717 | Overexpression of Macrophage Migration Inhibitory Factor and Its Homologue D-Dopachrome Tautomerase as Negative Prognostic Factor in Neuroblastoma |
| Q91050951 | Overexpression of macrophage migration inhibitory factor and functionally-related genes, D-DT, CD74, CD44, CXCR2 and CXCR4, in glioblastoma |
| Q37192606 | PIK3CA mutations in human solid tumors: role in sensitivity to various therapeutic approaches |
| Q60981619 | Parkinson’s disease is associated with increased serum levels of macrophage migration inhibitory factor |
| Q52715769 | Pathogenic role for macrophage migration inhibitory factor in glioblastoma and its targeting with specific inhibitors as novel tailored therapeutic approach. |
| Q39027987 | Pharmacological application of carbon monoxide ameliorates islet-directed autoimmunity in mice via anti-inflammatory and anti-apoptotic effects. |
| Q51767974 | Pharmacology and immune modulating properties of 5-androstene-3β,7β,17β-triol, a DHEA metabolite in the human metabolome. |
| Q60981620 | Phase II study of the antiretroviral activity and safety of the glucocorticoid receptor antagonist mifepristone in HIV-1-infected patients |
| Q55132704 | Physiologically based microenvironment for in vitro neural differentiation of adipose-derived stem cells. |
| Q72177243 | Placental thrombosis and fetal loss after passive transfer of mouse lupus monoclonal or human polyclonal anti-cardiolipin antibodies in pregnant naive BALB/c mice |
| Q24606795 | Potential use of rapamycin in HIV infection |
| Q50355256 | Preclinical evaluation of the PI3K/Akt/mTOR pathway in animal models of multiple sclerosis |
| Q45367564 | Prevalence of hepatitis C virus infection among health-care workers: A 10-year survey. |
| Q33982156 | Prevention and treatment of lethal murine endotoxemia by the novel immunomodulatory agent MFP-14. |
| Q74608576 | Prevention by rolipram of concanavalin A-induced T-cell-dependent hepatitis in mice |
| Q45068433 | Prevention of carrageenan-induced pleurisy in mice by anti-CD30 ligand monoclonal antibody |
| Q43629359 | Prevention of clinical and histological signs of proteolipid protein (PLP)-induced experimental allergic encephalomyelitis (EAE) in mice by the water-soluble carbon monoxide-releasing molecule (CORM)-A1. |
| Q43953636 | Prevention of diabetes in BB/Wor rats treated with monoclonal antibodies to interferon-gamma |
| Q73481254 | Prevention of endotoxin-induced lethality in neonatal mice by interleukin-13 |
| Q77642511 | Prevention of murine experimental autoimmune orchitis by recombinant human interleukin-6 |
| Q60981668 | Preventive and curative effects of cyclophosphamide in an animal model of Guillain Barrè syndrome |
| Q89049845 | Primary antiphospholipid syndrome and antiphospholipid syndrome associated to systemic lupus: Are they different entities? |
| Q47658675 | Proinflammatory effects of exogenously administered IL-10 in experimental autoimmune orchitis. |
| Q73966821 | Protection from concanavalin A (Con A)-induced T cell-dependent hepatic lesions and modulation of cytokine release in mice by sodium fusidate |
| Q72119420 | Protection from experimental autoimmune diabetes in the non-obese diabetic mouse with soluble interleukin-1 receptor |
| Q72293002 | Protection from experimental autoimmune thyroiditis in CBA mice with the novel immunosuppressant deoxyspergualin |
| Q34307356 | Ras/Raf/MEK/ERK and PI3K/PTEN/Akt/mTOR cascade inhibitors: how mutations can result in therapy resistance and how to overcome resistance |
| Q35679353 | Ras/Raf/MEK/ERK and PI3K/PTEN/Akt/mTOR inhibitors: rationale and importance to inhibiting these pathways in human health |
| Q37992546 | Resistance to TRAIL and how to surmount it. |
| Q28072650 | Roles of GSK-3 and microRNAs on epithelial mesenchymal transition and cancer stem cells |
| Q34966603 | Roles of the Raf/MEK/ERK and PI3K/PTEN/Akt/mTOR pathways in controlling growth and sensitivity to therapy-implications for cancer and aging |
| Q37865381 | Roles of the Ras/Raf/MEK/ERK pathway in leukemia therapy. |
| Q39801393 | Safety, bioavailability, and pharmacokinetics of VGX-1027-A novel oral anti-inflammatory drug in healthy human subjects |
| Q59089968 | Saquinavir-NO Inhibits IL-6 Production in Macrophages |
| Q45098771 | Saquinavir-NO inhibits S6 kinase activity, impairs secretion of the encephalytogenic cytokines interleukin-17 and interferon-gamma and ameliorates experimental autoimmune encephalomyelitis. |
| Q39389293 | Saquinavir-NO-targeted S6 protein mediates sensitivity of androgen-dependent prostate cancer cells to TRAIL. |
| Q93171990 | Senescence as a main mechanism of Ritonavir and Ritonavir-NO action against melanoma |
| Q44110178 | Serum concentrations of the interferon-gamma-inducible chemokine IP-10/CXCL10 are augmented in both newly diagnosed Type I diabetes mellitus patients and subjects at risk of developing the disease |
| Q73795611 | Serum levels of the interferon-gamma-inducing cytokine interleukin-18 are increased in individuals at high risk of developing type I diabetes |
| Q44121992 | Short-term prophylaxis with deoxyspergualin prevents testicular autoimmunity in mice |
| Q73869412 | Short-term treatment of relapsing remitting multiple sclerosis patients with interferon (IFN)-beta1B transiently increases the blood levels of interleukin (IL)-6, IL-10 and IFN-gamma without significantly modifying those of IL-1beta, IL-2, IL-4 and |
| Q73220460 | Sodium fusidate ameliorates the course of diabetes induced in mice by multiple low doses of streptozotocin |
| Q68299254 | Sodium fusidate and increased remission rate of insulin-dependent diabetes mellitus |
| Q36318497 | Sodium fusidate in Gillain-Barré syndrome: a case report |
| Q43709498 | Specific and strain-independent effects of dexamethasone in the prevention and treatment of experimental autoimmune encephalomyelitis in rodents |
| Q51443240 | Standardized bovine colostrum derivative impedes development of type 1 diabetes in rodents. |
| Q71255027 | Synergistic effect of deoxyspergualin (DSP) and cyclosporin A (CsA) in the prevention of spontaneous autoimmune diabetes in BB rats |
| Q38218970 | Targeting breast cancer initiating cells: advances in breast cancer research and therapy |
| Q37990970 | Targeting the cancer initiating cell: the ultimate target for cancer therapy. |
| Q37272565 | Targeting the leukemic stem cell: the Holy Grail of leukemia therapy |
| Q34173253 | Targeting the translational apparatus to improve leukemia therapy: roles of the PI3K/PTEN/Akt/mTOR pathway |
| Q94449533 | The Dichotomic Role of Macrophage Migration Inhibitory Factor in Neurodegeneration |
| Q38848393 | The NO-modified HIV protease inhibitor as a valuable drug for hematological malignancies: Role of p70S6K. |
| Q37192611 | The Raf/MEK/ERK pathway can govern drug resistance, apoptosis and sensitivity to targeted therapy |
| Q55416173 | The Role of Macrophages in Neuroinflammatory and Neurodegenerative Pathways of Alzheimer's Disease, Amyotrophic Lateral Sclerosis, and Multiple Sclerosis: Pathogenetic Cellular Effectors and Potential Therapeutic Targets. |
| Q60981654 | The analysis of IL-1 beta and its naturally occurring inhibitors in multiple sclerosis: The elevation of IL-1 receptor antagonist and IL-1 receptor type II after steroid therapy |
| Q73470129 | The antiinflammatory cytokine interleukin-13 is not detectable in the circulation of multiple sclerosis patients and is not inducible by interferon-beta1b treatment, that neither modifies its ex vivo secretion from peripheral blood mononuclear cells |
| Q34979356 | The antitumor properties of a nontoxic, nitric oxide-modified version of saquinavir are independent of Akt. |
| Q70527025 | The effects of a monoclonal antibody to interferon-gamma on experimental autoimmune thyroiditis (EAT): prevention of disease and decrease of EAT-specific T cells |
| Q68036903 | The effects of deoxyspergualin on the development of diabetes in diabetes-prone BB rats |
| Q39302816 | The immunobiology of apotransferrin in type 1 diabetes |
| Q77924893 | The involvement of IL-12 in murine experimentally induced autoimmune thyroid disease |
| Q64062093 | The neuropathic pain: An overview of the current treatment and future therapeutic approaches |
| Q34200994 | The new and less toxic protease inhibitor saquinavir-NO maintains anti-HIV-1 properties in vitro indistinguishable from those of the parental compound saquinavir |
| Q39850762 | The novel NO-donating compound GIT-27NO inhibits in vivo growth of human prostate cancer cells and prevents murine immunoinflammatory hepatitis |
| Q39763528 | The second-to-fourth digit ratio correlates with the rate of academic performance in medical school students. |
| Q38802412 | The therapeutic potential of mTOR inhibitors in breast cancer |
| Q26999245 | Therapeutic potential of carbon monoxide in multiple sclerosis |
| Q39313996 | Therapeutic potential of nitric oxide-modified drugs in colon cancer cells |
| Q37837732 | Therapeutic resistance resulting from mutations in Raf/MEK/ERK and PI3K/PTEN/Akt/mTOR signaling pathways. |
| Q90808298 | Transcriptomic Analysis Reveals Abnormal Expression of Prion Disease Gene Pathway in Brains from Patients with Autism Spectrum Disorders |
| Q91376793 | Transcriptomic Analysis Reveals Involvement of the Macrophage Migration Inhibitory Factor Gene Network in Duchenne Muscular Dystrophy |
| Q45922822 | Treatment with rapamycin ameliorates clinical and histological signs of protracted relapsing experimental allergic encephalomyelitis in Dark Agouti rats and induces expansion of peripheral CD4+CD25+Foxp3+ regulatory T cells. |
| Q39337196 | Unique antineoplastic profile of Saquinavir-NO, a novel NO-derivative of the protease inhibitor Saquinavir, on the in vitro and in vivo tumor formation of A375 human melanoma cells |
| Q57081512 | VGX-1027 modulates genes involved in lipopolysaccharide-induced Toll-like receptor 4 activation and in a murine model of systemic lupus erythematosus |
| Q56798234 | Vaccination with IL-6 analogues induces autoantibodies to IL-6 and influences experimentally induced inflammation |
| Q60981640 | Variable effects of cyclophosphamide in rodent models of experimental allergic encephalomyelitis |
| Q37927252 | Vitamin D3: a helpful immuno-modulator |
| Q39750949 | Yin Yang 1 overexpression in diffuse large B-cell lymphoma is associated with B-cell transformation and tumor progression |
| Q54586477 | mTOR as a multifunctional therapeutic target in HIV infection. |
| Ferdinando Nicoletti | wikipedia |
Search more.